**Table of Contents**

Page

[Web Links 4](#web-links)

[1. Introduction 5](#introduction)

[2. Overview 5](#overview)

[3. MOP Contents and Organization 6](#mop-contents-and-organization)

[3.1 Study Protocol 7](#study-protocol)

[3.2 Study Organization and Responsibilities
7](#study-organization-and-responsibilities)

[3.2.1 Roster 7](#roster)

[3.2.2 Coordinating Center 7](#coordinating-center)

[3.2.3 Study Sites 8](#study-sites)

[3.2.4 Pharmacy Activities 8](#pharmacy-activities)

[3.2.5 Steering Committees 8](#steering-committees)

[3.2.6 Other Study Committees 9](#other-study-committees)

[3.2.7 NCCIH 9](#nccih)

[3.3 Training Plan 9](#training-plan)

[3.4 Communications Plan 9](#communications-plan)

[3.5 Study Intervention 10](#study-intervention)

[3.6 Recruitment Plan 10](#recruitment-plan)

[3.7 Participant Retention 10](#participant-retention)

[3.8 Study Flow 11](#study-flow)

[3.9 Screening and Eligibility Criteria
11](#screening-and-eligibility-criteria)

[3.9.1 Screening Log 13](#screening-log)

[3.9.2 Eligibility Criteria 13](#eligibility-criteria)

[3.10 Informed Consent and HIPAA 13](#informed-consent-and-hipaa)

[3.10.1 HIPAA Authorization 13](#hipaa-authorization)

[3.11 Randomization 14](#randomization)

[3.12 Blinding and Unblinding (Masking and Unmasking)
14](#blinding-and-unblinding-masking-and-unmasking)

[3.13 Study Measurements and Procedures
15](#study-measurements-and-procedures)

[3.13.1 Timeline and Visit Schedule 15](#timeline-and-visit-schedule)

[3.13.2 Scope/Schema 15](#scopeschema)

[3.13.3 Final Study/Early Discontinuation Evaluations
15](#final-studyearly-discontinuation-evaluations)

[3.14 Concomitant Medication 16](#concomitant-medication)

[3.15 Safety Reporting 16](#safety-reporting)

[3.16 Study Compliance 16](#study-compliance)

[3.17 Data Collection and Study Forms
17](#data-collection-and-study-forms)

[3.17.1 Source Documentation 17](#source-documentation)

[3.17.2 Participant Binder 17](#participant-binder)

[3.17.3 Study Forms 17](#study-forms)

[3.17.4 General Instructions for Completing Forms
17](#general-instructions-for-completing-forms)

[3.18 Data Flow 19](#data-flow)

[3.19 Administrative Forms 19](#administrative-forms)

[3.20 Retention of Study Documentation
20](#retention-of-study-documentation)

[3.21 Data Management 20](#data-management)

[3.21.1 External Data 21](#external-data)

[3.22 Quality Control Procedures 22](#quality-control-procedures)

[3.22.1 Standard Operating Procedures
22](#standard-operating-procedures)

[3.22.2 Data and Form Checks 22](#data-and-form-checks)

[3.22.3 Double Data Entry 22](#double-data-entry)

[3.22.4 Site Monitoring 23](#site-monitoring)

[3.23 Reports 23](#reports)

[3.24 Data and Safety Monitoring Activities
24](#data-and-safety-monitoring-activities)

[3.25 Study Completion and Closeout Procedures
24](#study-completion-and-closeout-procedures)

[3.25.1 Participant Notification 25](#participant-notification)

[3.25.2 Site Procedures 25](#site-procedures)

[3.26 Policies 25](#policies)

[3.26.1 Confidentiality Procedures 25](#confidentiality-procedures)

[3.26.2 Publications 26](#publications)

[3.27 MOP Maintenance 27](#mop-maintenance)

[4. References 28](#references)

[Appendix A. Sample Screen Log 30](#appendix-a.-sample-screen-log)

[Appendix B. Sample Schedule of Events
31](#appendix-b.-sample-schedule-of-events)

[Appendix C. Sample Protocol Deviation Log 32](#_Toc424723934)

[Appendix D. Sample MOP Modification Log 33](#_Toc424723935)

